AKAgniete Kampaite

Agniete Kampaite

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Agniete Kampaite has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Disability-relevant demyelination in multiple sclerosis: five-year evolution following diagnosis

    by Elizabeth N. York, Rozanna Meijboom, Michael J. Thrippleton, Mark Bastin, Agniete Kampaite, Sarah-Jane Martin, Patrick K. A. Kearns, David Hunt, Siddharthan Chandran, Adam Waldman, et al.

    Improved understanding of how myelin damage contributes to disability in multiple sclerosis (MS) is needed to inform targeted therapeutic strategies and improve clinical trial platforms. Magnetization transfer saturation ( MTsat ) and T 1 relaxometry provide in vivo quantitative MRI measures of myelin integrity, and may offer insights into disability-relevant pathology beyond inflammatory relapse. This longitudinal study explores the relationship between early demyelination and disability progression over the first five years following diagnosis. 62 people with relapsing-remitting (pwRR)MS (≤ 6 months post-diagnosis, 48 female, mean age 38 years) underwent baseline and one-year MRI and Expanded Disability Status Scale (EDSS) assessment. At five-year follow-up, 56/62 (90.3%) completed EDSS and 40/62 additionally completed MRI (64.5%). Disability progression was defined as an increase of ≥ 1.5, ≥ 1.0 or ≥ 0.5 points for a previous EDSS score of < 1.0, 1.0 to 5.5, and ≥ 6.0, respectively. Baseline neurofilament light chain (NfL), glial fibrillary acidic protein (GFAP), and EBNA1 immunoglobulin (IgG) titres were also measured. MTsat was calculated within normal-appearing white matter (NAWM), white matter lesions (WML), cortical and deep grey matter (GM) structures. Associations between change in MTsat and disability progression were assessed with binomial logistic regression. Interactions with interval disease activity (i.e. new/enlarging lesions [NELs]) were investigated, and comparisons were made with healthy control test-retest data (n = 11). Exploratory analyses were performed for: (prolonged) T 1 ; baseline metrics; blood-derived markers; diffusion-weighted imaging; and, disability-associated differences in five-year microstructural MRI trajectories. Greater baseline-to-one-year decreases in NAWM and WML MTsat were associated with baseline-to-one-year disability progression (adjusted odds ratio [95% confidence interval] = 0.255 [0.078 to 0.602] and 0.261 [0.084 to 0.638]; false discovery rate [FDR]-corrected p -value = 0.015 and 0.015). NELs did not influence these associations (interaction p -values > 0.05). One-to-five-year changes in MTsat were not associated with one-to-five-year disability progression (FDR-corrected p -values > 0.05). Neither baseline nor baseline-to-one-year MTsat changes predicted future disability progression. No exploratory analyses reached FDR-corrected statistical significance. We show for the first time that progressive NAWM and WML demyelination measured with MTsat is associated with early disability progression in recently diagnosed RRMS, independent of radiological inflammatory disease activity. Neither MTsat nor T 1 are associated with longer-term progression over the subsequent four years. MTsat is sensitive to disability-relevant demyelination not visible on conventional MRI, indicates a potential early window of therapeutic opportunity in the year following diagnosis, and is a promising clinically applicable disease stratifier and surrogate endpoint for therapeutic trials.

  • Open Access

    Brain connectivity changes underlying depression and fatigue in relapsing-remitting multiple sclerosis: A systematic review

    by Agniete Kampaite, Rebecka Gustafsson, Elizabeth N. York, Peter Foley, Niall J. J. MacDougall, Mark E. Bastin, Siddharthan Chandran, Adam D. Waldman, Rozanna Meijboom

    Multiple Sclerosis (MS) is an autoimmune disease affecting the central nervous system, characterised by neuroinflammation and neurodegeneration. Fatigue and depression are common, debilitating, and intertwined symptoms in people with relapsing-remitting MS (pwRRMS). An increased understanding of brain changes and mechanisms underlying fatigue and depression in RRMS could lead to more effective interventions and enhancement of quality of life. To elucidate the relationship between depression and fatigue and brain connectivity in pwRRMS we conducted a systematic review. Searched databases were PubMed, Web-of-Science and Scopus. Inclusion criteria were: studied participants with RRMS (n ≥ 20; ≥ 18 years old) and differentiated between MS subtypes; published between 2001-01-01 and 2023-01-18; used fatigue and depression assessments validated for MS; included brain structural, functional magnetic resonance imaging (fMRI) or diffusion MRI (dMRI). Sixty studies met the criteria: 18 dMRI (15 fatigue, 5 depression) and 22 fMRI (20 fatigue, 5 depression) studies. The literature was heterogeneous; half of studies reported no correlation between brain connectivity measures and fatigue or depression. Positive findings showed that abnormal cortico-limbic structural and functional connectivity was associated with depression. Fatigue was linked to connectivity measures in cortico-thalamic-basal-ganglial networks. Additionally, both depression and fatigue were related to altered cingulum structural connectivity, and functional connectivity involving thalamus, cerebellum, frontal lobe, ventral tegmental area, striatum, default mode and attention networks, and supramarginal, precentral, and postcentral gyri. Qualitative analysis suggests structural and functional connectivity changes, possibly due to axonal and/or myelin loss, in the cortico-thalamic-basal-ganglial and cortico-limbic network may underlie fatigue and depression in pwRRMS, respectively, but the overall results were inconclusive, possibly explained by heterogeneity and limited number of studies. This highlights the need for further studies including advanced MRI to detect more subtle brain changes in association with depression and fatigue. Future studies using optimised imaging protocols and validated depression and fatigue measures are required to clarify the substrates underlying these symptoms in pwRRMS.


  • Segmentation of White Matter Hyperintensities and Ischaemic Stroke Lesions in Structural MRI

    by Jesse Phitidis, Alison Q. O’nEil, Stewart Wiseman, David Alexander Dickie, Eleni Sakka, Agniete Kampaite, William Whiteley, Miguel O. Bernabeu, Beatrice Alex, Joanna M. Wardlaw, et al.


  • Open Access

    Brain connectivity changes underlying depression and fatigue in relapsing-remitting multiple sclerosis: a systematic review

    by Agniete Kampaite, Rebecka Gustafsson, Elizabeth N. York, Peter Foley, Niall J. J. MacDougall, Mark E. Bastin, Siddharthan Chandran, Adam D. Waldman, Rozanna Meijboom

    Multiple Sclerosis (MS) is an autoimmune disease affecting the central nervous system, characterised by neuroinflammation and neurodegeneration. Fatigue and depression are common, debilitating, and intertwined symptoms in people with relapsing-remitting MS (pwRRMS). An increased understanding of brain changes and mechanisms underlying fatigue and depression in RRMS could lead to more effective interventions and enhancement of quality of life. To elucidate the relationship between depression and fatigue and brain connectivity in pwRRMS we conducted a systematic review. Searched databases were PubMed, Web-of-Science and Scopus. Inclusion criteria were: studied participants with RRMS and differentiated between MS subtypes; published between 2001-01-01 and 2023-01-18; used fatigue and depression assessments validated for MS; included brain structural, functional magnetic resonance imaging (fMRI) or diffusion MRI (dMRI). Sixty studies met the criteria: 18 dMRI (15 fatigue, 5 depression) and 22 fMRI (20 fatigue, 5 depression) studies. The literature was heterogeneous; half of studies reported no correlation between brain connectivity measures and fatigue or depression. Positive findings showed that abnormal cortico-limbic structural and functional connectivity was associated with depression. Fatigue was linked to connectivity measures in cortico-thalamic-basal-ganglial networks. Additionally, both depression and fatigue were related to altered cingulum structural connectivity, and functional connectivity involving thalamus, cerebellum, frontal lobe, ventral tegmental area, striatum, default mode and attention networks, and supramarginal, precentral, and postcentral gyri. Qualitative analysis suggests neuropathological effects, possibly due to axonal and/or myelin damage, in the cortico-thalamic-basal-ganglial and cortico-limbic network may underlie fatigue and depression in pwRRMS, respectively, but the overall results were inconclusive. This highlights the need for studies including advanced MRI to detect more subtle brain changes in association with depression and fatigue as functional and microstructural studies more consistently show correlations. Further studies using optimised imaging protocols and validated depression and fatigue measures are required to clarify the substrate underlying these symptoms in pwRRMS.